EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Facephi Biometria S.A. (ALPHI) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Facephi Biometria S.A. €0.70, price €1.80, upside -61.1%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Technology · FR

FB Some data Sep 24, 2026

Facephi Biometria S.A.

ALPHI · PA

Weakest SetupStrongly overvalued and low quality.

!Fair value €0.7000 · Strongly overvalued (−61.1%)
!Quality 40/100
!Expensive Growth (revenue 5y +37.7 %/yr)
!Thin margins · 0.8% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (5/13)
!Narrow moat 38/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 6 out of 100
Watch Facephi Biometria S.A. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€5.00 €1.48 Fair Value €0.7000 Aug 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range €1.48 – €5.00 · fair‑value band €0.4900 – €0.9200 · the €1.80 price screens above the €0.7000 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.

Follow Facephi Biometria in your weekly email

Every Wednesday you see whether Facephi Biometria is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Facephi Biometria, S.A. engages in the biometric facial recognition technology solutions in Spain and internationally.

Show more

Facephi Biometria, S.A. engages in the biometric facial recognition technology solutions in Spain and internationally. The company offers authentication, a solution allows user to authenticate through multibiometric technology and prevents unauthorized access; onboarding, a solution that allows to verify the identity of users remotely, automatically capturing the document information, and taking a selfie with passive liveness; and digital identity platform, that allows the customer to design any digital onboarding and authentication process that allows the customer to design any digital onboarding and authentication process. It also provides behavioural biometrics, an intelligent fraud detection solution; mule account detection for proactive protection against financial fraud; and Teseo ID wallet to manage verifiable credentials. Its solutions are used in banking, fintech, crypto, insurance, gaming and gambling, aviation, hospitality, shared mobility, government, telcos, health industries. Facephi Biometria, S.A. was incorporated in 2012 and is headquartered in Alicante, Spain.

Stock analysis

Facephi Biometria S.A. (ALPHI) currently trades at €1.80, while our model-based Fair Value estimate is €0.7000, 61.1% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of €0.7000 per share, and 3 of the 14 models we run sit above the €1.80 price.

Bear case: the Multiples group reads lowest at €0.3900, and 11 of the 14 models stay below the price. Evidence for this calculation is medium.

Scenario range: €0.4900 (bear) to €0.9200 (bull), the price of €1.80 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Technology sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Facephi Biometria S.A. reported revenue of €36.0M in FY2025 versus €13.2M in FY2021, a compound +28.6%/yr. Reported net income was €369K in FY2025.

Key figures

Market cap €47.7M · P/E ratio 180.0 · P/S ratio 1.84 · EPS (TTM) €0.0100 · Net margin 1.0% · Return on equity 1.6% · Return on assets (EBIT) −3.1% · Operating margin 20.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −8% fair-value upside, at −61%, ALPHI screens richer than that median.

Fair Value models

Bear €0.4900 Fair Value €0.7000 Bull €0.9200
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€0.0076 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV €0.9400 €1.05 €1.14 74
ROIC Compounder €1.05 €1.35 €1.57 70
Residual Income €0.5200 €0.4700 €0.4400 68
All 14 models by family
Earnings-Based
Graham-Dodd €0.0900 €0.6600 €0.9300 61
Lynch FV €0.3400 €0.4900 €0.6300 59
PEG = 1.0 €0.3400 €0.4900 €0.6300 55
EPV €0.9400 €1.05 €1.14 74
Multiples
P/E Multiple €0.2900 €0.3900 €0.4900 63
P/S Multiple €0.1800 €0.2400 €0.3000 58
P/B Multiple €0.1800 €0.2400 €0.3000 55
EV/EBIT €2.53 €3.35 €4.18 66
EV/EBITDA €5.37 €7.14 €8.91 67
EV/Revenue €1.31 €1.85 €2.38 54
Asset-Based
NCAV (Graham) €0.4100 €0.5500 €0.8200 54
Economic Profit
Residual Income €0.5200 €0.4700 €0.4400 68
ROIC Compounder €1.05 €1.35 €1.57 70
Growth Earnings
Growth-Adj P/E €0.4900 €0.7000 €0.9200 65

Open the full fair value analysis →

Notify me when ALPHI reaches fair value

Put ALPHI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 40/100

Of which business quality 42 · Market factors (momentum, volatility) 22

Profitability 39
Margins and returns on capital today
Quality Growth 100
Are margins and returns improving?
Cashflow 44
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 22
Disciplined investing over empire-building
Low Volatility 36
Calm price path (market factor)
Momentum 20
Price trend over the last 3–12 months (market factor)
52W Momentum 12
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+24.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+37.7%
Start year 2020 (pandemic). Over 10 years: +56.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+100.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−32.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−32.0%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−5% → 10%

ALPHI screens overvalued: fair value 61% below the price. Compare with SAP SE →

Compare Facephi Biometria S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 636 stocks

Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 40 · Bottom 25%
Fair Value upside −57.6% · Bottom 25%
Profitability
Return on equity (TTM) 1.6% · Below median
Return on assets 2.1% · Below median
Net margin (TTM) 0.8% · Below median
Operating margin (TTM) 20.5% · Top 25%
Growth and dividend
Revenue growth 32.0% · Top 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Software - Application median · lower = cheaper

P/E (TTM) 180.0× · Priciest 25%
P/B 2.46× · Pricier than median
P/S (TTM) 1.32× · Cheaper than median
EV/EBITDA 24.0× · Pricier than median
PEG 0.25× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 27
FUTURE (revenue growth)100 · sector 44
PAST (return on equity)6 · sector 19
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 30

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
SAP SE SAP €186.74 €172.46 −8%
Salesforce, Inc CRM $229.57 $342.73 +49%
Shopify Inc SHOP $144.01 $64.36 −55%
ServiceNow, Inc NOW $134.01 $147.41 +10%
Uber Technologies, Inc UBER $69.36 $103.69 +49%
Snowflake Inc SNOW $330.31 $74.36 −77%
Automatic Data Processing, Inc ADP $261.80 $150.01 −43%
Adobe Inc ADBE $239.94 $454.04 +89%
Datadog, Inc DDOG $268.70 $32.52 −88%
Cadence Design Systems, Inc CDNS $326.70 $225.48 −31%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Facephi Biometria S.A. · Fair Value
€0.7000 −61%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Facephi Biometria S.A. Fair Value". https://www.fairvalue-calculator.com/stock/ALPHI

Frequently asked questions

Is Facephi Biometria S.A. (ALPHI) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €0.7000 versus a price of €1.80, about −61% upside (overvalued).
What is the fair value of ALPHI?
Our model-based fair value for Facephi Biometria S.A. is €0.7000 (as of Sep 24, 2026), built from audited fundamentals. The current price: €1.80.
What is the quality score of ALPHI?
Facephi Biometria S.A. has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Facephi Biometria S.A. (ALPHI)?
Our model-based price target is the fair value of €0.7000 (as of Sep 24, 2026) from 14 valuation models. Cautious scenario €0.4900, optimistic scenario €0.9200. It is a calculation from audited fundamentals, not an analyst target.
What is the Facephi Biometria S.A. stock forecast for 2026?
Our models put fair value at €0.7000, about −61% upside versus a price of €1.80 (overvalued). Cautious scenario €0.4900, optimistic scenario €0.9200. The calculation is refreshed regularly with new filings.
What is the revenue of Facephi Biometria S.A. (ALPHI)?
Facephi Biometria S.A. reported trailing-twelve-month revenue of about €40.6M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Facephi Biometria S.A. (ALPHI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Facephi Biometria S.A. it is €0.7000 per share (as of Sep 24, 2026), against a price of €1.80. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Facephi Biometria S.A. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, ALPHI trades above its calculated fair value: price €1.80, fair value €0.7000, a gap of about −61% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALPHI?
No. The price is what the market pays today (€1.80); the fair value is what the company's own numbers justify (€0.7000). For Facephi Biometria S.A. the two are €1.10 per share apart. That gap is exactly why we show both numbers side by side.
How much is Facephi Biometria S.A. worth?
The market values Facephi Biometria S.A. at about €47.7M (market capitalisation, as of Sep 24, 2026). Per share that is €1.80; our models calculate a fair value of €0.7000 per share.
What do the bullish and bearish scenarios say about ALPHI?
Our models span a range for Facephi Biometria S.A.: cautious scenario €0.4900, base €0.7000, optimistic €0.9200 per share (as of Sep 24, 2026, price €1.80). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALPHI?
Facephi Biometria S.A. trades at a price-to-earnings ratio of 180.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €0.7000 is built from several models across several years. Other multiples: PEG 0.3, P/B 2.5, P/S 1.3, EV/EBITDA 24.0.
What is the PEG ratio of ALPHI?
The PEG ratio of Facephi Biometria S.A. is 0.25 (P/E divided by earnings growth, as of Sep 24, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Facephi Biometria S.A. (ALPHI)?
Balance-sheet figures for Facephi Biometria S.A. (as of Sep 24, 2026): return on equity 1.6%, debt of 0.01 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is ALPHI from its 52-week high?
Facephi Biometria S.A. trades at €1.80, about 37% below its 52-week high of €2.87 and 22% above the low of €1.48 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of €0.7000 is for.
Which stocks are comparable to Facephi Biometria S.A.?
From the same area (Technology) we also value SAP SE, Salesforce, Inc, Shopify Inc, ServiceNow, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Facephi Biometria S.A. stock attractive at the current price?
The data as of Sep 24, 2026: price €1.80, calculated fair value €0.7000 (−61%), Quality Score 40/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALPHI calculated?
We run Facephi Biometria S.A. through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.7000, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Facephi Biometria S.A. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Facephi Biometria S.A. (ALPHI)?
The closing price on Oct 2, 2026 was €1.80. Our model-based fair value is €0.7000, about −61% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Facephi Biometria S.A. right now?
The price sits above even our optimistic bull case (€0.9200). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (€0.4900 to €0.9200) leaves room in how you read the outcome.

Key figures of Facephi Biometria S.A.

How large is the market capitalisation of Facephi Biometria S.A. (ALPHI)?
The market capitalisation of Facephi Biometria S.A. is €47.7M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Facephi Biometria S.A. (ALPHI)?
The price-to-sales ratio of Facephi Biometria S.A. is 1.84 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Facephi Biometria S.A. (ALPHI)?
Earnings per share at Facephi Biometria S.A. are €0.0100 (price ÷ EPS = P/E 180.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Facephi Biometria S.A. (ALPHI)?
The net margin of Facephi Biometria S.A. is 1.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Facephi Biometria S.A. (ALPHI)?
The return on equity (ROE) of Facephi Biometria S.A. is 1.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Facephi Biometria S.A. (ALPHI)?
On an EBIT basis the return on assets of Facephi Biometria S.A. is −3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Facephi Biometria S.A. (ALPHI)?
The operating margin of Facephi Biometria S.A. is 20.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Facephi Biometria S.A. (ALPHI)?
Revenue at Facephi Biometria S.A. is growing +32.0% versus a year earlier (3y avg +17.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Facephi Biometria S.A. (ALPHI) generate?
The free cash flow of Facephi Biometria S.A. is −€1.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Facephi Biometria S.A. (ALPHI) carry?
The net debt of Facephi Biometria S.A. is €5.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Facephi Biometria S.A. in the live analysis

One click puts Facephi Biometria S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.